Skip to main content

Hydrogenase:For the Clean Energy Production


Introduction 
 Hydrogenase is a group of enzymes which has a able to produce and slid hydrogen. Such ability of the enzyme can be use to produce clean energy. An international team lead by researchers from UCL (UK) and CNRS (France), including an Ikerbasque Research Fellow from CIC nanoGUNE, have combined theory and experiment to characterize each chemical reaction step that results in the reduction of oxygen by the enzyme. These results have been published in the journal Nature Chemistry.

 History Of The Fossil Fuels.

Fossil fuels supply over 80% of the world's energy. Since the energy crises in 1970s and soon. Increased prices of fuel and low level of the fuel is a warning the world to wake and use the biotechnology and make efficient fuel. In the next step the scientist move to One possibility is using enzymes called hydrogenases that naturally occur in various microorganisms that live in anaerobic ecosystems, such as some bacteria living in soil and in the intestinal tract of animals, or unicellular algae.

 Mechanism

 Hydrogenases catalyze the conversion of protons in hydrogen molecules (H2), whose combustion releases energy that can be utilized for example in fuel cells and therefore be part of biotechnological devices. The active site that catalyzes this reaction contains metallic ions (Iron or both Iron and Nickel). The Iron-only variety of hydrogenases is the most active for the production of hydrogen molecules. Their remarkably complex active site -the so-called H-cluster- is buried within the core of a large protein. A fatal problem for being able to exploit hydrogenases in biotechnological applications is that when brought to the aerobic conditions of a bioreactor (under normal oxygen pressures), molecular oxygen degrades their active site. Understanding the mechanism of the degradation process of the H-cluster is therefore essential to design a hydrogen-based fuel cell, but studies so far had not been conclusive. To solve this conundrum, an international team of researchers has combined experiments, molecular simulations, and theoretical calculations. Using electrochemical methods, they have precisely measured the rates of the different reaction steps involved in the degradation of the enzyme by oxygen. They have studied the dependence of these rates on experimental parameters like the electrode potential, pH, H2O/D2O exchange, and mutation of specific amino acids in the protein. These results confirm predictions from theoretical calculations. The study published on August 22nd in Nature Chemistry has allowed to characterize unambiguously the complex reactions that occur in these large biological macromolecules using a highly innovative combination of computational and experimental approaches. "Although important challenges remain ahead for industrial applications, this study opens new avenues to efficiently exploit enzymes from living systems for clean energy production," says De Sancho.


 Source of the story: science daily


Comments

Popular posts from this blog

A Blood Test That Detects Early Alzheimer’s disease

A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy. In a “proof of concept” study involving 236 subjects, the test demonstrated an overall accuracy, sensitivity and specificity rate of 100 percent in identifying subjects whose MCI was actually caused by an early stage of Alzheimer’s disease. “About 60 percent of all MCI patients have MCI caused by an early stage of Alzheimer’s disease. The remaining 40 percent of cases are caused by other factors, including vascular issues, drug side-effects and depression. To provide proper care, physicians need to know which cases of MCI are due to early Alzheimer’s and which are not,” ...

The New Blood Group 'INRA'

Usually there are 4 or 5 blood groups to be known namely A,B,O,AB and rarely Bombay or HH blood group. The Bombay blood group are named after its discovery in the city Bombay (now called Mumbai city)discover by the Dr. Y.M. Bhende in 1952  and this is the first time India become a parent of the new and rarest type of blood group. It is obvious,Bomby blood group is the first blood group found in India but not the least "because discovery never stops" This saying fix here perfectly,A person with new & rare blood group is found in Lok Samparn Raktdan laboratory, Surat, Gujarat. The person’s blood group doesn’t match with any other A, B, O, AB and also Bombay Blood Group or also called as HH Blood Group. The new blood group is named as INRA; the first 2 letters represent India (IN) & the next two name of the person (RA). INRA blood group is identified for the first time when the person visited for donating blood in Blood Camp. The blood sample...

Artificial Cancer-Killing Virus

It is the genome of an oncolytic virus, it is 34,000 base pairs long, and it is 100% artificial. It’s important because it not only has immediate application in studies of canine cancer, it also promises to inform the development of human therapies. In these human therapies, artificial viruses could be customized to such an extent, that they could qualify as personalized anticancer therapeutics.  It is not the first time that oncolytic viruses has engineered but earlier virus like Herpes simplex and Oncorine(H101) are also being used.  The virus in question in sCAV2, a conditionally replicative adenovirus (CRAd) that can target and kill tumor cells while sparing healthy cells. It was synthesized by scientists affiliated with Gen9, who worked in concert with scientists representing Autodesk and Auburn University. At Auburn, scientists led by Bruce Smith, V.M.D., Ph.D., intend to use the synthetic virus to evaluate therapeutic treatments in dogs with osteosa...